share_log

莱美药业(300006.SZ)拟简易程序定增募资不超3亿元

Laimei Pharmaceutical (300006.SZ) plans a simplified procedure to raise no more than 300 million yuan

Zhitong Finance ·  Mar 17, 2023 20:40

According to the Zhitong Finance App, Laimei Pharmaceutical (300006.SZ) announced that the board of directors of the company requested the shareholders' meeting to authorize the board of directors to fully handle matters relating to the issuance of shares to specific targets through simplified procedures. The authorization period is from the date of approval of the 2022 Annual General Meeting of Shareholders to the date of the 2023 Annual General Meeting of Shareholders. The issuance price is not less than 80% of the average stock transaction price for the 20 trading days prior to the pricing benchmark date. The total amount of capital raised in this issue does not exceed 300 million yuan and does not exceed 20% of net assets at the end of the last year.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment